Russian pharmaceutical companies: Business models of market leaders

Research output: Contribution to journalArticlepeer-review


Many factors influence firms’ growth possibilities and market positions. This paper deals with business models as company’s competitiveness determinant; the case of Russian leading pharmaceutical companies is studied. The review of global pharmaceutical leaders’ business models is presented. Russian leaders are indentified basing on empirical data provided by SPARK database. It has been found that they use models of disruptive research, models aimed at business value growth as well as models of active portfolio management. Characteristics and perspectives of each model type are determined.

Original languageEnglish
Pages (from-to)127-138
Number of pages12
JournalVoprosy Ekonomiki
Issue number8
Publication statusPublished - Aug 2019


  • Business models
  • Pharmaceutical industry
  • Russian leading companies
  • business models
  • pharmaceutical industry

Fingerprint Dive into the research topics of 'Russian pharmaceutical companies: Business models of market leaders'. Together they form a unique fingerprint.

Cite this